Pharma IT
Where data integrity, automation and AI actually meet the plant floor.
ArticleAI Governance In Pharma: Is It Becoming The New GMP?
GMP built trust in physical manufacturing. Now algorithms need the same guardrails, here's why AI governance is following its playbook.
20260804110923.webp&w=1920&q=75&dpl=dpl_9xUZQSvr7qh8u3ierG8JmijXnhDf)
Can AI Decode the Gut? : Machine Learning in Microbiome Research
AI is decoding microbial patterns humans can't see. Here's how machine learning is transforming microbiome research into clinical reality.
How ML Virtual Screening Is Scaling Cancer Drug Targets?
ML virtual screening hits 18-45% in prospective trials vs sub-1% for HTS, unlocking undruggable cancer targets.
Schrodinger vs. Insilico Medicine: A Comparison Report
Physics vs generative AI for cancer drug design. Schrodinger and Insilico Medicine compared pipeline, deals, and proof.
The Patent Problem: Who Really Owns What AI Discovers in Science?
AI is discovering drugs but cannot own a patent. Explore who holds IP rights in AI-assisted pharma discovery and what your team must do.
When AI Gets It Wrong: The Real Patient Safety Risk of AI Hallucinations in Healthcare
AI hallucinations in pharma are a real patient safety risk. Wrong doses, false data, missed signals here's what governance looks like.
20260804112352.webp&w=1920&q=75&dpl=dpl_9xUZQSvr7qh8u3ierG8JmijXnhDf)
Is Pharma's AI Investment Actually Paying Off? Here's What the Numbers Say
Pharma AI ROI, pharmacovigilance and manufacturing deliver 1-3 year returns. Drug discovery takes 7-12 years. Real data, honest measurement framework.
20260804112641.webp&w=1920&q=75&dpl=dpl_9xUZQSvr7qh8u3ierG8JmijXnhDf)
How AI Is Changing the Way Pharma Research Teams Work
AI is reshaping pharma research teams, faster drug discovery, smarter decisions, and real results from companies already leading the shift.
How AI Is Changing Drug Safety Monitoring - And What the Future Looks Like
How AI transforms drug safety | signal detection, adverse event automation, real-world evidence integration, and pharmacovigilance team augmentation.
How AI-Native Biotech Companies Are Rewriting The Rules Of Drug Discovery
How AI-native biotech rewrites drug discovery | AlphaFold, platform models, generative molecule design, and partnerships reshaping pharma economics.
Key Takeaways from Pharma Now’s Webinar on AI in GxP with Dr. Ajaz Hussain
Watch the biggest takeaways from Pharma Now’s webinar on AI in GxP with Dr. Ajaz Hussain and what pharma IT leaders must do next.